A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LOAELs / lowest observed adverse effect levels

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LOAELs  (>> Co-occurring Abbreviation)
Long Form:   lowest observed adverse effect levels
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Chronic exposure to lead and cadmium pollution results in genomic instability in a model biomonitor species (Apodemus flavicollis Melchior, 1834). Cd
2020 In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection. ALI, AMPs, NCs, NSs, PNPs
2020 Neurotoxicity and apoptosis induced by pyrroloquinoline quinone and its ester derivative on primary cortical neurons. PQQ, PQQE
2018 Comparison of Anorectic Potencies of Type A Trichothecenes T-2 Toxin, HT-2 Toxin, Diacetoxyscirpenol, and Neosolaniol. BW, DAS, HT-2, i.p, NEO
2018 Modeling Chronic Toxicity: A Comparison of Experimental Variability With (Q)SAR/Read-Across Predictions. ---
2017 Permitted Daily Exposure of the Androgen Receptor Antagonist Flutamide. NMDR, PDE
2016 Abamectin:Avermectin (Pesticides). ADI, ARfD, FSCJ, NOAELs
2016 Assessment of synergistic thyroid disrupting effects of a mixture of EDCs in ovariectomized rats using factorial analysis and dose addition. AP, BMDLs, EDCs, PCBs, PTU
2015 Assessment of learning, memory and attention in developmental neurotoxicity regulatory studies: Introduction. DNT, EPA, OECD
10  2015 Comparison of Anorectic Potencies of the Trichothecenes T-2 Toxin, HT-2 Toxin and Satratoxin G to the Ipecac Alkaloid Emetine. DON, i.p, SG
11  2013 Does EU legislation allow the use of the Benchmark Dose (BMD) approach for risk assessment? BMD, EFSA, NOAELs
12  2013 The automated micronucleus assay for early assessment of genotoxicity in drug discovery. CBPI, RCC
13  2011 Potential carcinogenic hazards of non-regulated disinfection by-products: haloquinones, halo-cyclopentene and cyclohexene derivatives, N-halamines, halonitriles, and heterocyclic amines. DBPs, HAMs, HNs, HQs, NAs, NCls, NOM, QSTR
14  2010 A retrospective analysis of toxicity studies in dogs and impact on the chronic reference dose for conventional pesticide chemicals. EPA, RfD
15  2010 Risk assessment of an essential element: manganese. BMDs, CNS, Mn, MRI, NOAELs, PBPK
16  2010 Threshold dose for peanut: Risk characterization based upon diagnostic oral challenge of a series of 286 peanut-allergic individuals. ---
17  2008 Developmental toxicity of UV filters and environmental exposure: a review. UV
18  2008 The relationship of maternal and fetal toxicity in developmental toxicology bioassays with notes on the biological significance of the "no observed adverse effect level". ---
19  2007 Evaluation and application of the RD50 for determining acceptable exposure levels of airborne sensory irritants for the general public. ASTM, RELs, TLVs
20  2007 Interpretation of skeletal variations for human risk assessment: delayed ossification and wavy ribs. ---
21  2007 Sub-chronic toxicity of low concentrations of industrial volatile organic pollutants in vitro. MEK, TLVs
22  2006 A dose response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): reproductive effects on adult male offspring rats. BW, DEHP
23  2006 True prediction of lowest observed adverse effect levels. ITS, LDA, MLR
24  2005 Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. LNT
25  2005 Phenols, quinolines, indoles, benzene, and 2-cyclopenten-1-ones are oviductal toxicants in cigarette smoke. ---
26  2005 Postnatal development of rat pups after maternal exposure to diethanolamine. DEA, GD, NOAELs, PND
27  2005 Predictability and prediction of lowest observed adverse effect levels in a structurally heterogeneous set of chemicals. EPA, LDA, MLR, NTP
28  2005 Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate. NOAELs, PBPK, PGME, RfC, RfD
29  2004 Comparison of risk assessment methodologies for exposure of mink to PCBs on the Kalamazoo River, Michigan. FC, HQ, KRAOC, TEQs, TRVs
30  2004 Pyrazine derivatives in cigarette smoke inhibit hamster oviductal functioning. ---
31  2002 Identification of pyridine compounds in cigarette smoke solution that inhibit growth of the chick chorioallantoic membrane. CAM
32  1998 Developmental toxicity of carbendazim: comparison of no-observed-adverse-effect level and benchmark dose approach. BD, NOAELs
33  1998 The use of hematological effects in the development of minimal risk levels. ATSDR, MRLs, NOAELs
34  1995 Functional aspects of developmental toxicity of polyhalogenated aromatic hydrocarbons in experimental animals and human infants. PCBs, PCDDs, PCDFs, TEF, TEQs
35  1994 Summary of the workshop on issues in risk assessment: quantitative methods for developmental toxicology. ---
36  1994 The ecotoxicological significance of cadmium intake and residues in terrestrial small mammals. ---
37  1991 Reproductive toxicity of commercial PCB mixtures: LOAELs and NOAELs from animal studies. NOAELs, PCB
38  1990 Neurotoxicology dose/response assessment for several cholinesterase inhibitors: use of uncertainty factors. ADI, NOAELs, RfD, RfDs